Cited by 85Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsEndometriosis Research and Treatment

Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: a randomized, double-blind, and placebo control trial

Fux Otta, Carolina, Wior, Myriam, Iraci, Gabriel S., Kaplan, Raquel, Torres, Diana, Gaido, María Isabel, Wyse, Eduardo P.·2010·Gynecological Endocrinology

Abstract

The aim of this study was to evaluate the effects of metformin in addition to diet and exercise on endocrine and metabolic disturbances in women with polycystic ovary syndrome (PCOS) in a prospective, double-blind, randomized, placebo (PBO) control trial. Thirty women with insulin resistance and PCOS received lifestyle modification and 1500 mg of metformin or placebo for 4 months. Before and after treatment, body mass index, waist/hip ratio, blood pressure, hirsutism, and menstrual patterns were evaluated. Serum concentrations of gonadotropins, androgens, progesterone, glucose, insulin, and lipids were measured. Lifestyle interventions resulted in similar weight and menstrual cycle's improvements in both groups. A significant reduction in serum fasting insulin, HOMA index, waist and testosterone levels was only observed with metformin. There were no significant changes in androstenedione, dehydroepiandrosterone sulfate, gonadotropins, and lipids levels. No other changes were observed in hirsutism or blood pressure. These findings suggest that metformin has an additive effect to diet and exercise to improve parameters of hyperandrogenism and insulin resistance. Although, a small decrease in body weight trough lifestyle changes could be enough to improve menstrual cycles in insulin-resistant women with PCOS.

Integrity signals

Registry

Crossref · 10.3109/09513590903215581

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Fux Otta, C., Wior, M., Iraci, G. S., Kaplan, R., Torres, D., Gaido, M. I., & Wyse, E. P.
Affiliations
  • Hospital Privado (AR)
  • Universidad Nacional de Córdoba (AR)
Venue
Gynecological Endocrinology
Published
2010-02-12
Volume
26
Issue
3
Pages
173-178
ISSN
  • 0951-3590 (ISSN-L)
  • 1473-0766
OpenAlex
W2003741958
Cited by
85
References
46
Citations by year
2026: 3 · 2025: 5 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 4 · 2020: 10 · 2019: 4 · 2018: 2 · 2017: 2 · 2016: 8 · 2015: 9 · 2014: 6 · 2013: 1 · 2012: 9
FWCI
7.21
Type
journal article
Language
en
Open access
closed
Locations
  • Gynecological Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
Keywords
polycystic ovary syndrome, metformin, lifestyle intervention, diet and exercise, insulin resistance, hyperandrogenism, menstrual cycle, hirsutism, fasting insulin, HOMA index, testosterone, body weight, gonadotropins, androgens, blood pressure
MeSH terms
Adult, Blood Pressure, Cholesterol, Double-Blind Method, Female, Follicle Stimulating Hormone, Hirsutism, Humans, Hypoglycemic Agents, Insulin Resistance, Luteinizing Hormone, Life Style, Menstrual Cycle, Metformin, Polycystic Ovary Syndrome, Testosterone, Triglycerides, Body Mass Index, Statistics, Nonparametric, Waist-Hip Ratio, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review